An Open Source Model to Measure Value Jennifer Bright, MPA - - PowerPoint PPT Presentation

an open source model to measure value
SMART_READER_LITE
LIVE PREVIEW

An Open Source Model to Measure Value Jennifer Bright, MPA - - PowerPoint PPT Presentation

An Open Source Model to Measure Value Jennifer Bright, MPA Executive Director, Innovation and Value Initiative @IVI_Health September 20, 2019 Jennifer Bright, MPA Disclosures Rela latio ionship ip Company ny(ies es) Speakers Bureau


slide-1
SLIDE 1

An Open Source Model to Measure Value

Jennifer Bright, MPA

Executive Director, Innovation and Value Initiative @IVI_Health September 20, 2019

slide-2
SLIDE 2

2

Jennifer Bright, MPA

Disclosures

Rela latio ionship ip Company ny(ies es) Speakers Bureau Advisory Committee National Health Council Board Membership Mental Health America Consultancy Cancer Support Community, FasterCures Review Panel Honorarium National Health Council Ownership Interests Momentum Health Strategies, LLC

slide-3
SLIDE 3

3

Status Quo Models for Value Assessment

  • What is missing?
  • Real-world data on patient quality
  • f life and value perspectives
  • Other cost factors important to

payers

  • Multiple methods for analysis
  • Transparency about how the

model works

slide-4
SLIDE 4

4

Employers and Value

  • Employers understand value in a broader context of total cost of

care, but need reliable tools and information that can help them make immediate decisions

  • Employers are not really in a position to do value assessments

themselves; outsourced analysis

  • Are third parties delivering comprehensive insight on value?
  • Employers may not engage directly in value assessment,

but they also stand to lose a lot if it is not done well

slide-5
SLIDE 5

5

Making a Difference…

  • The Innovation and Value Initiative (IVI) is an independent 501c3

research organization created to raise the level of discussion around value in healthcare by bringing together all participants in the system – academics, patients, patient advocates, payers, life sciences companies, providers, delivery systems, and other stakeholders – to find common ground in the approach for measuring value.

  • MISSION: Advance the science and improve the practice of value

assessment in healthcare.

  • GOAL: Build a platform that facilitates robust and rigorous patient-

centered value assessment of health technologies to the needs and interests of individual decision-makers.

slide-6
SLIDE 6

6

IVI envisions a healthcare system that rewards value based on its core principles.

slide-7
SLIDE 7

7

Key Elements to a Better Discussion About Value

  • Patient involvement and perspective first
  • Transparent environment for development and solutions
  • Methods focus – finding new ways to interpret information to

give insight and drive better discussion and dialogue

  • Iterative methods improvement
  • Develop and test ways to incorporate real-world data
slide-8
SLIDE 8

8

The Open Source Value Platform

  • IVI developed the Open-Source Value

Platform (OSVP) as a new approach to assessing value.

  • The OSVP is a transparent and open-

source system for estimating the value

  • f medical technologies in a way that

centers on the patient, allows for a broad range of perspectives, incorporates the latest available evidence, and considers the full range

  • f scientifically defensible

approaches.

slide-9
SLIDE 9

9

slide-10
SLIDE 10

10 Darius N. Lakdawalla, Jalpa A. Doshi, Louis P. Garrison, Charles E. Phelps, Anirban Basu, Patricia M. Danzon, Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3], Value in Health, Volume 21, Issue 2, 2018, Pages 131-139. Accessed at https://doi.org/10.1016/j.jval.2017.12.007.

slide-11
SLIDE 11

11

A Look Into the Future

  • Value assessment models that extend beyond Rx to medical

devices, technologies, and other therapeutic modalities

  • Value assessment models that expand beyond clinical data to

include real-world patient perspectives and considerations, including risk tolerance, out of pocket expenses, desire for independent living, and lived experience

  • Value assessment models that consider and quantify multiple

perspectives (e.g. patients and their caregivers)

slide-12
SLIDE 12

12

Essential Questions

  • Does your internal analysis focus solely on clinical evidence (i.e.,

randomized control trial data) or does it also incorporate real-world data sources? Which sources are used to understand patient experience in treatment and patient subgroup response to treatments?

  • Does your value assessment evaluate treatment factors that are

important to patients and their caregivers and may have an impact on indirect costs? How?

  • Our employees and their families represent a diverse population both

demographically and with respect to health status and needs. What are your steps and approaches to ensure that your recommendations to us for benefit design and management reflects that diversity?

slide-13
SLIDE 13

13

The Bottom Line

  • Value needs to address factors important to both patient and employer

perspectives

  • Employers (and their employees) need to know that the health coverage they

are paying for is delivering the highest value of care:

  • Optimized for time and patient characteristics and circumstances
  • Optimized for clinical and cost impacts
  • Value assessment should be able to:
  • Facilitate an analysis relevant to an employer’s specific population they cover (versus a

generalized population)

  • Offer flexible analysis over time that accommodates new evidence, new methods and new

decision questions

  • Incorporate multiple methods for comparison and compatibility to localized needs
slide-14
SLIDE 14

14

Thank You!

Jennifer Bright, MPA Executive Director, Innovation and Value Initiative @IVI_Health September 20, 2019